AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimith MF 4mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Johnlee Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (500mg)

Overview Glimith MF 4mg/500mg Tablet SR

Diabetic patients using Glimith MF 4mg/500mg SR tablets, an anti-diabetic combination medication, should adhere to prescribed dosages. This dual-action formulation manages blood glucose in adult type 2 diabetes. Consistent daily intake, ideally with meals, maximizes effectiveness; dosage adjustments are determined by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks hyperglycemia and complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Hypoglycemia (low blood sugar), manifested by sweating, dizziness, headaches, and tremors, is a common adverse effect. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain is also a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (including complete blood count and liver function tests) are recommended by your doctor.

Uses of Glimith MF 4mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimith MF 4mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimith MF 4mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Glimith MF 4mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimith MF 4mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimith MF 4mg/500mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

How Glimith MF 4mg/500mg Tablet SR works:

Glimith MF 4mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimith MF 4mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimith MF 4mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimith MF 4mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimith MF 4mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimith MF 4mg/500mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimith MF 4mg/500mg Tablet SR cautiously, potentially requiring dose modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiating therapy with a low dose of Glimith MF 4mg/500mg Tablet SR is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimith MF 4mg/500mg Tablet SR :

Should you forget a Glimith MF 4mg/500mg SR Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimith MF 4mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimith MF 4mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimith MF 4mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimith MF 4mg/500mg Tablet SR and seek immediate medical attention.
Glimith MF 4mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimith MF 4mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Glimith MF 4mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological symptoms such as tingling, numbness in the extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimith MF 4mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimith MF 4mg/500mg SR tablets with alcohol is unsafe. Alcohol can further lower blood sugar, risking hypoglycemia, and increase the risk of lactic acidosis.
Glimith MF 4mg/500mg Tabl...
56
MRP 65
13% off